GT BIOPHARMA, INC.

Analyst Reco. GT Biopharma, Inc.

Equities

GTBP

US36254L3087

Market Closed - Nasdaq Other stock markets 03:58:36 2024-06-04 pm EDT			5-day change	1st Jan Change
3.57 ^USD	+0.14%		+1.13%	-53.33%

May. 21	Top Midday Decliners	MT
May. 21	GT Biopharma Prices $3.2 Million Registered Direct Offering of Shares, Concurrent Private Placement of Warrants	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EF Hutton Starts GT Biopharma at Hold With $2 Price Target	23-01-05	MT
HC Wainwright Adjusts Price Target on GT Biopharma to $5 From $25, Reiterates Buy Rating	22-09-13	MT
Roth Capital Cuts GT Biopharma to Neutral From Buy, Price Target to $3 From $9	22-08-12	MT
B. Riley Lowers GT Biopharma's Price Target to $18 from $26 After Revising Cost Capital Assumptions, Keeps Buy Rating	22-01-24	MT
GT BIOPHARMA : B. Riley Raises GT Biopharma's PT to $26 from $21, Notes Steady Progress of Dose-Escalation Trial of Lead Asset GTB-3550; Keeps Buy Rating	21-06-24	MT
GT BIOPHARMA : HC Wainwright Starts GT Biopharma at Buy With $25 Price Target	21-05-24	MT
GT BIOPHARMA : B. Riley Starts GT Biopharma at Buy with $21 PT, Says Solid Tumor Indications Represent Source of Potential Upside	21-04-13	MT
GT BIOPHARMA : Roth Capital Starts GT Biopharma at Buy With $25 Price Target	21-03-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer